Literature DB >> 18416545

Application of belief theory to similarity data fusion for use in analog searching and lead hopping.

Steven W Muchmore1, Derek A Debe, James T Metz, Scott P Brown, Yvonne C Martin, Philip J Hajduk.   

Abstract

A wide variety of computational algorithms have been developed that strive to capture the chemical similarity between two compounds for use in virtual screening and lead discovery. One limitation of such approaches is that, while a returned similarity value reflects the perceived degree of relatedness between any two compounds, there is no direct correlation between this value and the expectation or confidence that any two molecules will in fact be equally active. A lack of a common framework for interpretation of similarity measures also confounds the reliable fusion of information from different algorithms. Here, we present a probabilistic framework for interpreting similarity measures that directly correlates the similarity value to a quantitative expectation that two molecules will in fact be equipotent. The approach is based on extensive benchmarking of 10 different similarity methods (MACCS keys, Daylight fingerprints, maximum common subgraphs, rapid overlay of chemical structures (ROCS) shape similarity, and six connectivity-based fingerprints) against a database of more than 150,000 compounds with activity data against 23 protein targets. Given this unified and probabilistic framework for interpreting chemical similarity, principles derived from decision theory can then be applied to combine the evidence from different similarity measures in such a way that both capitalizes on the strengths of the individual approaches and maintains a quantitative estimate of the likelihood that any two molecules will exhibit similar biological activity.

Mesh:

Substances:

Year:  2008        PMID: 18416545     DOI: 10.1021/ci7004498

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  43 in total

1.  The errors of our ways: taking account of error in computer-aided drug design to build confidence intervals for our next 25 years.

Authors:  Terry Richard Stouch
Journal:  J Comput Aided Mol Des       Date:  2012-01-14       Impact factor: 3.686

2.  Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles.

Authors:  Paul A Clemons; Nicole E Bodycombe; Hyman A Carrinski; J Anthony Wilson; Alykhan F Shamji; Bridget K Wagner; Angela N Koehler; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-18       Impact factor: 11.205

3.  Comparison of structure fingerprint and molecular interaction field based methods in explaining biological similarity of small molecules in cell-based screens.

Authors:  Pekka Tiikkainen; Antti Poso; Olli Kallioniemi
Journal:  J Comput Aided Mol Des       Date:  2008-12-03       Impact factor: 3.686

4.  Muscarinic receptors as model targets and antitargets for structure-based ligand discovery.

Authors:  Andrew C Kruse; Dahlia R Weiss; Mario Rossi; Jianxin Hu; Kelly Hu; Katrin Eitel; Peter Gmeiner; Jürgen Wess; Brian K Kobilka; Brian K Shoichet
Journal:  Mol Pharmacol       Date:  2013-07-25       Impact factor: 4.436

5.  ALOHA: a novel probability fusion approach for scoring multi-parameter drug-likeness during the lead optimization stage of drug discovery.

Authors:  Derek A Debe; Ravindra B Mamidipaka; Robert J Gregg; James T Metz; Rishi R Gupta; Steven W Muchmore
Journal:  J Comput Aided Mol Des       Date:  2013-10-11       Impact factor: 3.686

6.  Herman Skolnik award symposium honoring Yvonne Martin.

Authors:  Wendy A Warr
Journal:  J Comput Aided Mol Des       Date:  2009-12-10       Impact factor: 3.686

7.  Quantifying structure and performance diversity for sets of small molecules comprising small-molecule screening collections.

Authors:  Paul A Clemons; J Anthony Wilson; Vlado Dančík; Sandrine Muller; Hyman A Carrinski; Bridget K Wagner; Angela N Koehler; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

8.  Prediction and evaluation of protein farnesyltransferase inhibition by commercial drugs.

Authors:  Amanda J DeGraw; Michael J Keiser; Joshua D Ochocki; Brian K Shoichet; Mark D Distefano
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

9.  Chemical structural novelty: on-targets and off-targets.

Authors:  Emmanuel R Yera; Ann E Cleves; Ajay N Jain
Journal:  J Med Chem       Date:  2011-09-14       Impact factor: 7.446

10.  Identification of Cys255 in HIF-1α as a novel site for development of covalent inhibitors of HIF-1α/ARNT PasB domain protein-protein interaction.

Authors:  Rosa Cardoso; Robert Love; Carol L Nilsson; Simon Bergqvist; Dawn Nowlin; Jiangli Yan; Kevin K-C Liu; Jing Zhu; Ping Chen; Ya-Li Deng; H Jane Dyson; Michael J Greig; Alexei Brooun
Journal:  Protein Sci       Date:  2012-11-09       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.